Angiopoietin-2 and outcome in patients with acute decompensated heart failure

[1] McMurray JJ(2012)ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur J Heart Fail 14 803-869

[2] Adamopoulos S(2008)Cardiogenic shock: current concepts and improving outcomes Circulation 117 686-697

[3] Anker SD(2009)Bench-to-bedside review: Angiopoietin signalling in critical illness—a future target? Crit Care 13 207-29

[4] Auricchio A(2000)Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-Kinase/Akt signal transduction pathway Circ Res 86 24-239

[5] Böhm M(2006)Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation Nat Med 12 235-4156

[6] Dickstein K(2004)The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies Blood 103 4150-780

[7] Falk V(2005)The Tie-2 ligand Angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism J Cell Sci 118 771-1851

[8] Filippatos G(2010)Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients Crit Care Med 38 1845-2300

[9] Fonseca C(2010)Circulating angiopoietins in idiopathic pulmonary arterial hypertension Eur Heart J 31 2291-12180

[10] Gomez-Sanchez MA(2004)Hypoxic regulation of angiopoietin-2 expression in endothelial cells J Biol Chem 279 12171-206

[1] McMurray JJ(2012)ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur J Heart Fail 14 803-869

[2] Adamopoulos S(2008)Cardiogenic shock: current concepts and improving outcomes Circulation 117 686-697

[3] Anker SD(2009)Bench-to-bedside review: Angiopoietin signalling in critical illness—a future target? Crit Care 13 207-29

[4] Auricchio A(2000)Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-Kinase/Akt signal transduction pathway Circ Res 86 24-239

[5] Böhm M(2006)Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation Nat Med 12 235-4156

[6] Dickstein K(2004)The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies Blood 103 4150-780

[7] Falk V(2005)The Tie-2 ligand Angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism J Cell Sci 118 771-1851

[8] Filippatos G(2010)Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients Crit Care Med 38 1845-2300

[9] Fonseca C(2010)Circulating angiopoietins in idiopathic pulmonary arterial hypertension Eur Heart J 31 2291-12180

[10] Gomez-Sanchez MA(2004)Hypoxic regulation of angiopoietin-2 expression in endothelial cells J Biol Chem 279 12171-206